Key facts
- This page summarizes James E. Dentzer's Form 4 filing for Imunon, Inc. (IMNN).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 18 Mar 2025, 16:18.
James E. Dentzer - 14 Mar 2025 Form 4 Insider Report for Imunon, Inc. (IMNN)
- Role
- Director
- Signature
- /s/ Susan Eylward, Attorney-in-Fact for James E. Dentzer
- Issuer symbol
- IMNN
- Transactions as of
- 14 Mar 2025
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 18 Mar 2025, 16:18:42 UTC
- Previous filing
- 30 Jan 2025
- Next filing
- 22 May 2025
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
James E. Dentzer filed Form 4 for Imunon, Inc. (IMNN) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 30 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
IMNN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,750
- Change %
- Price
- $0.000000
- Shares after
- 3,750
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,750
- Exercise price
- $0.8651
- Footnotes
- F1, F2
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents the closing price of Imunon, Inc. Common Stock on the date of grant. |
| F2 | The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. |